Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
Soleno Therapeutics (NASDAQ: SLNO), a clinical-stage biopharmaceutical company focused on rare disease therapeutics, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's management will engage in a fireside chat on Thursday, December 5, 2024, at 9:00 AM Eastern Time. Interested parties can access both the live audio webcast and replay through the Investors section of Soleno's website at www.soleno.life.
Soleno Therapeutics (NASDAQ: SLNO), un'azienda biofarmaceutica in fase clinica focalizzata sulle terapie per malattie rare, ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler. La direzione dell'azienda parteciperà a un incontro informale giovedì 5 dicembre 2024, alle 9:00 ora orientale. Le parti interessate possono accedere sia alla diretta audio in streaming che alla registrazione nella sezione Investitori del sito web di Soleno all'indirizzo www.soleno.life.
Soleno Therapeutics (NASDAQ: SLNO), una empresa biofarmacéutica en etapa clínica centrada en terapias para enfermedades raras, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. La dirección de la empresa participará en una charla informal el jueves 5 de diciembre de 2024, a las 9:00 AM, hora del Este. Las partes interesadas pueden acceder tanto a la transmisión de audio en vivo como a la repetición a través de la sección de Inversores del sitio web de Soleno en www.soleno.life.
Soleno Therapeutics (NASDAQ: SLNO)는 희귀 질환 치료제에 중점을 둔 임상 단계의 생명공학 회사로, Piper Sandler 제36회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 관리팀은 2024년 12월 5일 목요일 오전 9시(동부 표준시)에 분위기 있는 대화에 참여할 예정입니다. 관련자들은 www.soleno.life의 투자자 섹션을 통해 생중계 오디오와 다시보기를 이용할 수 있습니다.
Soleno Therapeutics (NASDAQ: SLNO), une entreprise biopharmaceutique en phase clinique axée sur les thérapies pour les maladies rares, a annoncé sa participation à la 36e Conférence Annuelle sur la Santé de Piper Sandler. La direction de l'entreprise participera à une discussion informelle le jeudi 5 décembre 2024, à 9h00, heure de l'Est. Les parties intéressées peuvent accéder à la diffusion audio en direct ainsi qu'à la rediffusion via la section Investisseurs du site Web de Soleno à l'adresse www.soleno.life.
Soleno Therapeutics (NASDAQ: SLNO), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf Therapien für seltene Krankheiten konzentriert, hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler bekannt gegeben. Das Management des Unternehmens wird am Donnerstag, den 5. Dezember 2024, um 9:00 Uhr Eastern Time an einem informellen Gespräch teilnehmen. Interessierte Parteien können sowohl auf die Live-Audioübertragung als auch auf die Wiederholung über den Bereich Investoren auf der Website von Soleno unter www.soleno.life zugreifen.
- None.
- None.
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Thursday, December 5, 2024, at 9:00 AM Eastern Time.
A live audio webcast and replay of the fireside chat will be available in the Investors section on the Company’s website at www.soleno.life.
About Soleno Therapeutics, Inc.
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. An NDA for its lead candidate, DCCR (diazoxide choline) extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS) is currently under review by the FDA and was granted Priority Review. For more information, please visit www.soleno.life.
Corporate Contact:
Brian Ritchie
LifeSci Advisors, LLC
212-915-2578
FAQ
When is Soleno Therapeutics (SLNO) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch Soleno Therapeutics' (SLNO) presentation at the Piper Sandler Conference?
What type of event will Soleno Therapeutics (SLNO) participate in at the Piper Sandler Conference?
